Belantamab mafodotin for relapsed or refractory multiple myeloma: A real-world observational study update Meeting Abstract
| Authors: | Hultcrantz, M.; Kleinman, D.; Vij, R.; Escalante, F.; Delforge, M.; Kotowsky, N.; Bitetti, J.; Boytsov, N.; Camadoo-O'Byrne, L.; Happ, L. P.; Rohman, M.; Germain, G.; Duh, M. S.; LaliberteĢ, F.; Mahendran, M.; Urosevic, A.; Lee, H. |
| Abstract Title: | Belantamab mafodotin for relapsed or refractory multiple myeloma: A real-world observational study update |
| Meeting Title: | 11th Annual Meeting of the Society of Hematologic Oncology (SOHO 2023): Progress in Personalized Therapy |
| Keywords: | multiple myeloma; evidence; real-world; belantamab mafodotin; relapsed/refractory multiple myeloma |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Sep 6-9 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S504 |
| Language: | English |
| ACCESSION: | WOS:001062479600592 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01461-1 |
| Notes: | Meeting Abstract: MM-508 -- Source: Wos |
